➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Colorcon
McKinsey
Boehringer Ingelheim
Mallinckrodt

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

ENOXAPARIN SODIUM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Enoxaparin Sodium patents expire, and when can generic versions of Enoxaparin Sodium launch?

Enoxaparin Sodium is a drug marketed by Amphastar Pharms Inc, Sandoz Inc, Amphastar Pharm, Apotex Inc, Nanjing King-friend, Sandoz, and Teva. and is included in seven NDAs.

The generic ingredient in ENOXAPARIN SODIUM is enoxaparin sodium. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Enoxaparin Sodium

A generic version of ENOXAPARIN SODIUM was approved as enoxaparin sodium by SANDOZ INC on November 28th, 2011.

  Start Trial

Drug patent expirations by year for ENOXAPARIN SODIUM
Drug Prices for ENOXAPARIN SODIUM

See drug prices for ENOXAPARIN SODIUM

Recent Clinical Trials for ENOXAPARIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xijing HospitalPhase 2/Phase 3
Hamilton Health Sciences CorporationPhase 1
Les Laboratoires des Médicaments StérilesPhase 4

See all ENOXAPARIN SODIUM clinical trials

Pharmacology for ENOXAPARIN SODIUM
Medical Subject Heading (MeSH) Categories for ENOXAPARIN SODIUM
Paragraph IV (Patent) Challenges for ENOXAPARIN SODIUM
Tradename Dosage Ingredient NDA Submissiondate
LOVENOX (PRESERVATIVE FREE) INJECTABLE;SUBCUTANEOUS enoxaparin sodium 020164 2006-12-07
LOVENOX INJECTABLE;INTRAVENOUS, SUBCUTANEOUS enoxaparin sodium 020164 2006-12-07

US Patents and Regulatory Information for ENOXAPARIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-002 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-001 Jul 23, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-003 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-006 Jul 23, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Colorcon
McKinsey
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.